CD22 p.Ala798Val
c.2393C>T · VCV3487948
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0521 | likely benign |
|---|---|---|
| REVEL | 0.06 | moderately benign-leaning |
| SaProt | LLR -4.92 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.1 | GERP -0.44, phastCons 1 |
| Regional constraint | o/e 0.88 | unconstrained · MANE · 15 kb · p 7.1e-05 · regional, not allelic |
| Overall | ||
| CADD | 13.87 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Middle Easterngrpmax | 0.0165% | 6,062 |
| Admixed American | 0.015% | 6,670 |
| European (non-Finnish) | 0.00805% | 12,419 |
| Remaining individualsnot grpmax-eligible | 0.008% | 12,500 |
| South Asian | 0.00549% | 18,216 |
| African / African-American | 0.00266% | 37,527 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CD22
- Protein
- p.Ala798Val
- Coding
- c.2393C>T
- MANE Select
- NM_001771
- Type
- single nucleotide variant
- Location
- chr19:35346216 (GRCh38)
- Gene constraint
- LOEUF 0.639 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 79.33 · 7 PDB
Similar variants
- CD22 p.Ala391Thr Benign ★★ same type
- CD22 p.Cys265= Benign ★★ same type
- CD22 p.Gly551Arg Benign ★★ same type
- CD22 p.Gly727Ser Likely benign ★★ same type
- CD22 p.Pro681= Benign ★★ same type
- CD22 p.Ala17Val Uncertain significance ★ ⚠ same type
- CD22 p.Ala498Ser Uncertain significance ★ ⚠ same type
- CD22 p.Ala656Thr Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cd22-p-ala798val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown